ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 262

$477K Total Retail Price of All Prescriptions

Rank: 26 out of 262

446 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,643 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 646 643 1 1
LISINOPRIL 557 539 2 3
LEVOTHYROXINE SODIUM 428 419 3 2
FUROSEMIDE 393 373 4 4
HYDROCHLOROTHIAZIDE 356 356 5 7
METOPROLOL SUCCINATE 321 317 6 11
METOPROLOL TARTRATE 283 276 7 8
AMLODIPINE BESYLATE 273 273 8 6
HYDROCODONE-ACETAMINOPHEN 266 246 S3 9 15
SERTRALINE HCL 264 252 10 14
POTASSIUM CHLORIDE 214 214 11 10
DONEPEZIL HCL 212 212 12 23
OMEPRAZOLE 199 199 13 5
METFORMIN HCL 193 193 14 9
LOSARTAN POTASSIUM 159 159 15 17
ATORVASTATIN CALCIUM 142 133 16 13
GABAPENTIN 142 129 16 19
TRAMADOL HCL 136 131 18 18
ALLOPURINOL 123 111 19 22
JANTOVEN 113 111 20 39
PREDNISONE 111 106 21 29
DIGOXIN 107 105 22 28
ATENOLOL 107 92 22 16
ISOSORBIDE MONONITRATE ER 103 103 24 33
ADVAIR DISKUS 101 101 25 34
ALENDRONATE SODIUM 98 98 26 21
WARFARIN SODIUM 94 94 27 12
ENALAPRIL MALEATE 94 94 27 27
CARVEDILOL 93 93 29 31
TRIAMTERENE-HCTZ 90 79 30 32
FENOFIBRATE 84 84 31 77
SPIRIVA 80 74 32 61
ZOLPIDEM TARTRATE 80 80 32 26
POLYETHYLENE GLYCOL 3350 79 79 34 42
GLIPIZIDE XL 77 77 35 87
OXYBUTYNIN CHLORIDE 76 76 36 90
PRAVASTATIN SODIUM 74 73 37 41
FLUOXETINE HCL 73 73 38 46
FAMOTIDINE 67 67 39 65
PROAIR HFA 63 60 40 53
METOCLOPRAMIDE HCL 62 62 41 124
GLIPIZIDE ER 59 59 42 143
OXYBUTYNIN CHLORIDE ER 58 58 43 102
VENLAFAXINE HCL ER 58 58 43 79
BISOPROLOL-HYDROCHLOROTHIAZIDE 54 54 45 112
CLOPIDOGREL 52 52 46 38
NEXIUM 50 38 47 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.